Aivlosin

RSS

tylvalosin

Authorised
This medicine is authorised for use in the European Union.

Overview

Aivlosin is an antibiotic used to treat a number of infectious diseases in pigs, chickens, pheasants and turkeys.

In pigs, Aivlosin is used to treat and for metaphylaxis of several infections caused by bacteria that affect the lungs (i.e. swine enzootic pneumonia) or the intestinal tract (swine dysentery or porcine proliferative enteropathy). Metaphylaxis means giving a medicine to a group of animals, aiming to treat animals sick with an infection while controlling spread of the infection among the rest, some of whom may already be infected. Aivlosin improves the health and weight of the animals but it may not eliminate completely the bacteria that caused lung infection.

In chickens and pheasants, Aivlosin is used for treatment and metaphylaxis of lung infections caused by the bacterium Mycoplasma gallisepticum.

In turkeys, Aivlosin is used to treat lung infections caused by a bacterium, Ornithobacterium rhinotracheale, which can cause illness when it is complicated by other viral and bacterial infections.

Aivlosin contains the active substance tylvalosin (previously called acetylisovaleryltylosin).

This EPAR was last updated on 20/11/2020

Authorisation details

Product details
Name
Aivlosin
Agency product number
EMEA/V/C/000083
Active substance
tylvalosin
International non-proprietary name (INN) or common name
tylvalosin
Species
  • Pheasants
  • Chicken
  • Turkeys
  • Pigs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QJ01FA92
Publication details
Marketing-authorisation holder
ECO Animal Health Europe Limited
Revision
31
Date of issue of marketing authorisation valid throughout the European Union
09/09/2004
Contact address

ECO Animal Health Europe Limited
6th Floor, South Bank House
Barrow Street
Dublin 4 D04 TR29
Ireland

Product information

12/11/2020 Aivlosin - EMEA/V/C/000083 - IAIN/0084

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Antiinfectives for systemic use

  • Antibacterials for systemic use

  • Macrolides

Therapeutic indication

Pigs

  • Treatment and methaphylaxis of swine enzootic pneumonia;
  • Treatment of porcine proliferative enteropathy (ileitis);
  • Treatment and methaphylaxis of swine dysentery.

Chickens

  • Treatment and methaphylaxis of respiratory disease associated with Mycoplasma gallisepticum in chickens.

Pheasants

  • Treatment of respiratory disease associated with Mycoplasma gallisepticum.

Turkeys

  • Treatment of respiratory disease associated with tylvalosin sensitive strains of Ornithobacterium rhinotracheale in turkeys.

Assessment history

Changes since initial authorisation of medicine

News

How useful was this page?

Add your rating
Average
1 rating